Quarterly Trends in Past-month Cannabis Use in the United States, 2015-2019
Overview
Authors
Affiliations
Background: Prevalence of cannabis use has been increasing among select subgroups in the US; however, trend analyses typically examine prevalence of use across years. We sought to determine whether there is seasonal variation in use.
Methods: We conducted a secondary analysis of the National Survey on Drug Use and Health, a repeated cross-sectional survey of nationally representative probability samples of noninstitutionalized populations age ≥12 in the US. Quarterly trends in any past-month cannabis use were estimated using data from 2015-2019 (N = 282,768).
Results: Prevalence of past-month cannabis use increased significantly from 2015 to 2019 from 8.3%-11.5%, a 38.2 % increase (P < 0.001). Prevalence increased across calendar quarters on average from 8.9 % in January-March to 10.1 % in October-December, a 13.0 % increase (P < 0.001). Controlling for survey year and participant demographics, each subsequent quarter was associated with a 6% increase in odds for use (aOR=1.06, 95 % CI: 1.04-1.07). There were significant increases by quarter among all subgroups of sex, race/ethnicity, education, and among most adult age groups (Ps<0.05), with a 52.7 % increase among those age ≥65. Prevalence also significantly increased among those without a medical cannabis prescription and those not proxy-diagnosed with cannabis use disorder (Ps<0.01), suggesting recreational use may be driving increases more than medical or more chronic use. Those reporting past-year LSD or blunt use in particular were more likely to report higher prevalence of use later in the year (a 4.9 % and 3.3 % absolute increase, respectively; Ps<0.05).
Conclusion: The prevalence of cannabis use increases throughout the year, independently of annual increases.
Meena P, Sharma A, Maurya A, Bansal V Indian J Psychiatry. 2024; 66(8):736-743.
PMID: 39398511 PMC: 11469565. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_141_24.
Dyar C, Herry E, Pirog S Soc Sci Med. 2024; 358:117261.
PMID: 39178534 PMC: 11403871. DOI: 10.1016/j.socscimed.2024.117261.
The Elusive Truth of Cannabinoids for Rheumatic Pain.
Clarke H, Miles S, Peer M, Fitzcharles M Curr Rheumatol Rep. 2024; 26(11):392-402.
PMID: 39120750 DOI: 10.1007/s11926-024-01162-9.
Tinsley S, Arora S, Stephens A, Finati M, Chiarelli G, Cirulli G World J Urol. 2024; 42(1):465.
PMID: 39090376 DOI: 10.1007/s00345-024-05151-6.
Prevalence of and trends in current cannabis use among US youth and adults, 2013-2022.
Mattingly D, Richardson M, Hart J Drug Alcohol Depend Rep. 2024; 12:100253.
PMID: 39040476 PMC: 11262189. DOI: 10.1016/j.dadr.2024.100253.